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Leaving no one Behind
Equity of resource flows for reproductive, 
maternal, newborn, and child health: are those 
most in need being left behind?
Although equity has improved in recent years, donors and country governments still need to 
improve the amount and targeting of funding for reproductive, maternal, and child health, say 
Melisa Martinez-Alvarez and colleagues
Financing is a crucial determi-nant of whether all women, chil-dren, and adolescents receive the care they need without risk of impoverishment—the goal of 
universal health coverage. To achieve the 
aim of leaving no one behind, as set out in 
the sustainable development goals, both 
financing (how resources are raised) and 
funding (how resources are distributed) 
must be equitable—that is, raised according 
to ability to pay and distributed according 
to need.
Although equity of health financing 
can be assessed at global, national, and 
subnational levels, most studies of equity 
have been conducted at the national and 
subnational levels because financing 
policy is considered the domain of 
national governments. Existing studies 
have tracked donor funding for specific 
dimensions of women’s, children’s, 
and adolescents’ health (particularly 
reproductive, maternal, newborn, and 
child health (RMNCH)1-5); however, few 
have investigated equity of donor funds. 
Analyses of domestic funding for RMNCH 
have been limited by fragmented and 
scarce data.6 7 Yet, anticipated decreases in 
donor financing and increased emphasis 
on mobilising domestic health financing8 
may have important equity implications, 
making assessment of equity of resources 
increasingly urgent at global, national, and 
subnational levels.
How do we define equitable resource flows?
Equity is a core part of the universal health 
coverage agenda, but little guidance exists 
on what equitable funding for RMNCH 
resembles or how it should be assessed.
In our analysis (box 1) we identify four 
dimensions of equity, defined by the type 
of resource flow and the type of equity. We 
distinguish between two types of resource 
flows: financial contributions (who pays) 
and funding allocation (who benefits).9 
Regarding equity, we distinguish between 
horizontal equity (equal treatment for equal 
need or ability to pay) and vertical equity 
(unequal treatment for unequal need or 
ability to pay).13 A situation may therefore 
be considered equitable when
•	 Those who have similar ability to pay 
contribute equally (horizontally equi-
table financing)
•	 Those with greater ability to pay con-
tribute more (vertically equitable 
financing)
•	 Those with equal need benefit equally 
from RMNCH funding (horizontally 
equitable funding), and
•	 Those with greater need receive more 
funding (vertically equitable funding).
Any given situation may be considered 
equitable along all, none, or some of these 
dimensions. We do not consider other 
concerns regarding funding, including 
efficiency, country ownership, predictability, 
sustainability, aid dependency, or fungibility 
(whether governments reduce domestic 
health financing in response to external 
funding).14-16
We consider three financing sources: 
out of pocket, domestic government, and 
external contributions. Out-of-pocket 
contributions from households are con-
sidered least equitable because they 
represent a higher share of income for the 
poor.17 Domestic government contributions, 
mainly from taxation, are considered more 
equitable than out-of-pocket expenditures 
as these usually require the richer to 
pay more (although the degree of equity 
depends on the taxation system and who 
contributes to taxes).18 External funding, 
which comprises a sizeable part of revenue 
in low and middle income countries (28% 
of health funding to low income countries 
in 201610), originates primarily from 
taxation and voluntary contributions from 
residents of (predominantly) high income 
countries. It is therefore equitable from 
a global perspective as it redistributes 
resources from richer to poorer populations.
Progress in equity of who finances services
Using the Muskoka2 method we estimate 
that donor aid for RMNCH increased by 
42% between 2010 and 2017 among 
donors that reported data for both years 
(average annual rates of increase, 5.1%).4 
This represents an improvement in verti-
cal equity at a global level. However, while 
these increases substantially outpaced 
increases in overall aid, they were similar 
to increases in aid for the health sector, sug-
gesting that prioritisation of RMNCH within 
the health sector has remained constant.4
Our assessment was limited by the 
small number of data points within the 
Global Health Expenditure Database 
(GHED). As expected, per capita domestic 
Key Messages
• 		Since 2002 the distribution of exter-
nal funding to reproductive, maternal, 
newborn, and child health (RMNCH) 
has become more equitable and bet-
ter targeted at the poorest countries 
and those experiencing the highest 
mortality
• 		The aid envelope is not large enough 
or well enough concentrated to close 
gaps in domestic government fund-
ing between the poorest and middle 
income countries
• 		Donors and governments of low 
and middle income countries should 
increase their investments for RMNCH
• 		Donors should further concentrate 
their funds on the poorest countries 
and those with the highest maternal, 
newborn, and child mortality
• 		Investment is also needed to close 
serious data and methodological 
gaps for assessing equity of financing 
between and within countries
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government expenditures were higher 
in (comparatively) richer countries than 
in poorer countries (fig 1). Contributions 
from countries of similar income, however, 
varied substantially. For example, across 
14 low income countries, domestic 
government expenditure on reproductive 
health in 2016 varied from $0.2 (constant 
2016 purchasing power parity, PPP) per 
capita in the Democratic Republic of the 
Congo to $8.2 in Burkina Faso. Similarly, 
across 17 lower middle income countries, 
domestic government expenditure on 
reproductive health in 2016 varied from 
$3.9 per capita in Nigeria to $59 in the 
Republic of the Congo (fig 1). Domestic 
financing of reproductive health exceeded 
donor financing in nine of the 15 low 
income countries and in all 14 lower 
middle income and five upper middle 
income countries, while domestic financing 
of child health exceeded donor financing in 
three of five low income countries and both 
upper middle income countries for which 
data were available (fig 2).
Progress in equity of who benefits
Our analysis of Muskoka2 data shows that 
the distribution of donor funding is verti-
cally equitable with respect to income, as 
poorer countries generally receive higher 
amounts of funding than richer ones, as 
concentration curves were all above the 
line of equality (fig 3). From 2002 to 2017, 
RMNCH funding became increasingly con-
centrated among the poorest countries; 
concentration curves moved further from 
the line of equality (concentration index 
changed from −0.36 to −0.57). For exam-
ple, the poorest countries, comprising 10% 
of the world’s population, received 33% of 
donor funding for RMNCH in 2002, 42% 
in 2010, and 47% in 2017. However, we 
found countries of broadly similar income 
levels received increasingly different levels 
of aid for RMNCH between 2002 and 2017 
(indicating decreasing horizontal equity) 
(fig 4).
When using mortality as a measure of 
need, we found donor funding for child 
health was concentrated among countries 
with higher child death rates (above 
the line of equality in fig 3). This shows 
vertical equity, but the small decrease in the 
concentration index between 2002 (−0.25) 
and 2017 (−0.32) indicates vertical equity 
improved only marginally. Differences 
between the levels of donor funding for 
child health received by countries with 
similar death rates increased over the 
same period, indicating aid for child health 
became less horizontally equitable (fig 4).
In 2002, aid for maternal and newborn 
health was close to the line of equality 
(concentration index=−0.06), indicating 
no correlation with need, but became 
increasingly concentrated among countries 
with higher neonatal death rates (indicated 
by an upward shift of the concentration 
curve, fig 3). By 2017, the concentration 
index for aid for maternal and newborn 
health reached −0.31, almost equal to that 
of child health funding (web supplement). 
Differences in funding per birth received by 
countries with similar neonatal mortality 
grew between 2002 and 2010, indicating 
donor funding for maternal and newborn 
health became less horizontally equitable; 
this pattern remained similar in 2017 
(fig 4).
We used the GHED to assess the 
distribution of funding from combined 
domestic government and external 
sources in relation to country income and 
health need and found deep inequities 
(fig 5). Countries with the highest child 
and maternal mortality received the least 
child and reproductive health funding, 
indicating funding is vertically inequitable. 
Funding was also horizontally inequitable, 
with substantial variability across countries 
with similar needs. Guinea, for example, 
has one of the highest neonatal death 
rates—over 40 deaths/1000 live births—
but received just $6 per capita in combined 
domestic government and external funding 
for reproductive health in 2016 (fig 5). For 
countries with data on family planning in 
2016, combined domestic government and 
external expenditures were higher across 
three upper middle income countries 
(mean $2.9 per capita, range: $0.7- $5.2) 
than nine lower middle income countries 
($1.9, $0.2-$6.4) and 13 low income 
countries ($1.7, $0.1-$6.1), with wide 
variation within income groups (see web 
supplement).
Our assessment of trends in equity for 
RMNCH funding is tentative given the 
small number of data points available 
in GHED. For countries with more than 
one year of data, we examine changes 
in combined domestic government and 
external funding between that country’s 
first and last reported year. For reproductive 
health, we found that only four of 13 low 
income countries, nine of 14 lower middle 
income countries, and two of three upper 
middle income countries had expenditure 
increases (web supplement). For family 
planning, about half of low income (6/12) 
and lower middle income (3/7) countries, 
and all three upper middle income 
countries had expenditure increases (web 
supplement).
Box 1: Assessment methods
We use two databases to analyse equity of resource flows between and within countries (see 
web supplement). To assess donor flows across 150 aid recipient countries from 2002 to 
2017, we use the Muskoka2 approach4 applied to the creditor reporting system (CRS) of the 
Organisation for Economic Cooperation and Development.9 To assess domestic government 
and external expenditure, we analyse the World Health Organization’s Global Health 
Expenditure Database (GHED).10 Data specific to aspects of RMNCH were available for only 
a limited number of countries (range 9 to 39) and years (2010 to 2016), and so we restrict our 
analysis to data on reproductive health (including maternal and newborn health and family 
planning) and children under 5 in 2016.
Available financing data did not allow for a financing incidence analysis, a method typically 
used to assess equity of financial contributions,11 or analysis of out-of-pocket financing. We 
therefore instead assess equity of RMNCH financing between countries by comparing trends 
in the total amount of donor financing for RMNCH between 2002 and 2017, using Muskoka2 
data. We also used the GHED to compare domestic government RMNCH contributions in 
2016 between countries of similar and different income groups. To assess equity of financing 
within countries, we compare the relative contributions of external and domestic government 
financing of RMNCH using GHED data.
To analyse equity of funding allocation, we compare donor and domestic government 
funding to metrics of need. We assess funding and need at the country level because available 
data did not allow assessment at the individual level or by sub-national geographical area. 
We measure need as income (GDP per capita) and neonatal and under 5 death rates. We use 
Muskoka2 data to plot concentration curves and calculate concentration indices12 for donor 
funding for the years 2002, 2010, and 2017. To analyse the distribution of combined donor 
and domestic government RMNCH funding according to need, we use GHED data for 2016, 
graphed as bar charts (comparing funding by income group) and scatter plots (comparing 
funding by neonatal and child mortality).
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Priorities and challenges
The increases in donor funding for RMNCH 
from 2010 to 2017 are encouraging signs 
of improvement in equity globally. The 
distribution of aid for RMNCH also became 
more vertically equitable over this period, 
in that donors increasingly prioritised 
lower income countries and those with 
higher mortality. However, concerns 
remain regarding the horizontal equity of 
donor funds, as countries of similar income 
groups and health needs received increas-
ingly different funding levels. As expected, 
domestic government expenditure on 
reproductive health (including maternal 
health and family planning) and children 
under 5 tended to be higher in higher 
income countries, although with substan-
tial variation. Assessment of trends over 
time was hampered by lack of data but sug-
gests that combined domestic government 
and external expenditure for RMNCH in low 
and middle income countries has increased 
more in the higher income countries than 
in the poorest countries. This is concern-
ing because it suggests external funds for 
RMNCH are insufficient to overcome the 
low levels of domestic government funding 
in some of the poorest countries, leaving 
women and children vulnerable to impov-
erishing expenditure and possibly worse 
health outcomes.
The global community has placed 
increasing emphasis on domestic finan-
cing,8 in part because of concerns that 
governments may become dependent on 
external funds, potentially decreasing 
contributions to areas prioritised by 
donors. Although donors consider many 
factors when allocating resources, 
substantial inequities between countries 
with the greatest ability to pay and those 
with the greatest health needs will continue 
to widen unless governments and donors 
substantially increase their funding and 
further improve targeting to those most in 
need.
Assessing equity of resource flows 
remains challenging because of data 
and methodological limitations. Data 
limitations prevented us from examining 
out-of-pocket financing at all levels 
and equity of RMNCH funding within 
countries. WHO must be commended 
for its work with countries to collect and 
share data through the GHED. However, 
the number of countries reporting funding 
data for RMNCH priorities is limited, those 
countries with data report for only a limited 
number of years, and no data are available 
on out-of-pocket expenditure for RMNCH, 
which severely limits any assessment of 
the equity of financing. While data on total 
health funding are much more complete, 
data on funding for other disease or 
population groups (eg, non-communicable 
diseases) are also scarce. 
Limitations of the Muskoka2 approach 
have been extensively  discussed 
elsewhere.4 Muskoka2 is applied to data9 
that include many but not all donors 
(China’s contributions to aid financing, 
for example, are not included), and 
in which aid is categorised by sector 
and specific subsectoral areas, none of 
which are specific to child health. The 
Muskoka2 approach therefore uses various 
assumptions to disaggregate aid specific to 
RMNCH from aid for other areas. Although 
these estimates have been developed 
through expert opinion and previous 
analyses of funding distribution,4 they are 
necessarily uncertain.
Improved methods are needed to assess 
and monitor equity. Consensus is needed 
on which funds should be considered to 
benefit RMNCH. Global tracking initiatives 
such as Muskoka2, for example, consider 
a proportion of health systems financing 
to benefit RMNCH, but there is currently 
no analogous approach for domestic 
expenditures. Better methods are also 
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Fig 1 | Domestic government and external expenditure on reproductive, maternal, and neonatal health per capita in 2016 (constant 2016 $ PPP), 
separated by country income group (World Bank 2017 groupings.19 Data from the Global Health Expenditure Database10
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Fig 2 | Domestic government and external 
expenditure on child health per capita in 
2016 (constant 2016 $ PPP), separated by 
country income group (World Bank 2017 
groupings19). Data from the Global Health 
Expenditure Database10
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necessary to track funding for adolescents, 
who have different health needs and access 
to services from other age groups and yet 
use many of the same services. 
Finally, assessing progress requires a 
definition of what equitable financing 
for RMNCH would look like. We have 
discussed the importance of considering 
both horizontal and vertical equity, both 
for “who pays for” and “who benefits” 
from RMNCH resource flows, and shown 
the potential to apply this approach both 
globally and within countries. However, 
important questions remain. Out-of-
pocket financing is widely recognised as 
the least equitable of financing sources, 
but there is no agreement on whether 
donor or domestic government funds are 
more equitable. In an extreme case, aid 
funds from the wealthiest donor may be 
seen as more equitable than funds from 
poor citizens in the poorest country, but 
the equity is less clear for funds from a 
middle income donor. Ultimately these 
assessments are difficult to make without 
data on the source of funds, both from 
donors and from the tax base of recipient 
countries. 
We recognise taking a global lens to 
equity may generate debate, particularly 
within the donor community, which 
considers many issues beyond equity when 
allocating funds. We hope to provide an 
empirical base for debate, and to contribute 
towards development of more robust 
methods to assess equity at the global level. 
More country level studies are also needed 
to assess the subnational equity of resource 
flows for RMNCH.
Conclusions
To achieve the sustainable development 
goals and universal health coverage, the 
international community must focus on 
countries—and populations within them—
with highest needs. Despite many limita-
tions of the available data, our analysis 
suggests that external RMNCH funding 
favours countries of lower income and 
higher mortality levels but is not suffi-
cient or sufficiently targeted to overcome 
the deep inequities in domestic funding. 
Countries of similar needs continue to 
receive different funding levels. Although it 
is vertically equitable that poorer countries 
receive more aid than better-off countries, 
combined donor and domestic govern-
ment funding levels remain inequitable 
across low and middle income countries. 
The result is that countries with the low-
est income and highest mortality levels 
are at risk of being left behind in global 
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Fig 4 | Horizontal equity of donor funds for 
reproductive, maternal, neonatal and child 
health (RMNCH) between 2002 and 20174: 
aid to RMNCH by maternal and neonatal 
health (top), aid for child health by number 
of children under 5 (middle), and aid to 
maternal, and neonatal health per birth 
(bottom). Countries are grouped respectively 
by neonatal mortality, under 5 mortality, 
and country income group to show within 
group horizontal inequity. Countries were 
categorised using the World Bank’s income 
groups based on 2017 data19
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Fig 3 | Vertical equity of donor funds for 
reproductive, maternal, neonatal and child 
health (RMNCH) between 2002 and 2017.4 
Concentration curves showing the alignment 
of global aid to RMNCH with different 
measures of need in 2002, 2010, and 2017 
(only countries with available data are 
shown). If the curve is above the (diagonal) 
line of equality, funding is concentrated 
among those with greater need, whereas if 
the curve falls below the line of equality, the 
funding distribution favours those with lesser 
need
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improvements. To improve equity within 
and between countries, domestic govern-
ment expenditure on RMNCH should be 
increased, although the extent to which 
governments are able to do so depends on 
many factors, including national income. 
To close gaps between countries and 
increase equity globally, donors need to 
increase their prioritisation of countries 
with the highest levels of mortality and 
the least ability to pay. We call for greater 
investment in producing and scrutinising 
data on resource flows for women, chil-
dren, and adolescents.
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Fig 5 | Combined domestic government and 
donor funding for reproductive, maternal, 
neonatal, and child health by neonatal and 
under 5 mortality in 2016 (constant 2016 
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